Bank of America’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $311M | Buy |
3,883,419
+2,212,208
| +132% | +$182M | 0.02% | 553 |
|
|
2025
Q4 | $142M | Sell |
1,671,211
-96,872
| -5% | -$7.95M | 0.01% | 905 |
|
|
2025
Q3 | $138M | Sell |
1,768,083
-579,042
| -25% | -$45.2M | 0.01% | 1018 |
|
|
2025
Q2 | $184M | Buy |
2,347,125
+199,806
| +9% | +$14.9M | 0.01% | 834 |
|
|
2025
Q1 | $156M | Buy |
2,147,319
+574,273
| +37% | +$41.1M | 0.01% | 844 |
|
|
2024
Q4 | $116M | Sell |
1,573,046
-850,210
| -35% | -$59.5M | 0.01% | 944 |
|
|
2024
Q3 | $160M | Sell |
2,423,256
-1,305,611
| -35% | -$94.9M | 0.01% | 829 |
|
|
2024
Q2 | $344M | Buy |
3,728,867
+311,309
| +9% | +$27.6M | 0.03% | 475 |
|
|
2024
Q1 | $327M | Buy |
3,417,558
+587,932
| +21% | +$49.4M | 0.03% | 490 |
|
|
2023
Q4 | $216M | Sell |
2,829,626
-53,240
| -2% | -$3.7M | 0.02% | 589 |
|
|
2023
Q3 | $200M | Sell |
2,882,866
-2,483,219
| -46% | -$200M | 0.02% | 586 |
|
|
2023
Q2 | $506M | Buy |
5,366,085
+84,134
| +2% | +$7.31M | 0.05% | 317 |
|
|
2023
Q1 | $437M | Buy |
5,281,951
+226,319
| +4% | +$17.8M | 0.04% | 361 |
|
|
2022
Q4 | $377M | Sell |
5,055,632
-388,955
| -7% | -$30M | 0.04% | 392 |
|
|
2022
Q3 | $450M | Sell |
5,444,587
-363,565
| -6% | -$35M | 0.05% | 325 |
|
|
2022
Q2 | $552M | Buy |
5,808,152
+142,444
| +3% | +$14.7M | 0.06% | 292 |
|
|
2022
Q1 | $667M | Buy |
5,665,708
+336,263
| +6% | +$37.7M | 0.06% | 276 |
|
|
2021
Q4 | $690M | Sell |
5,329,445
-321,316
| -6% | -$37.5M | 0.07% | 283 |
|
|
2021
Q3 | $640M | Sell |
5,650,761
-96,077
| -2% | -$11M | 0.07% | 286 |
|
|
2021
Q2 | $595M | Buy |
5,746,838
+81,267
| +1% | +$7.66M | 0.06% | 304 |
|
|
2021
Q1 | $474M | Buy |
5,665,571
+81,163
| +1% | +$6.86M | 0.05% | 331 |
|
|
2020
Q4 | $509M | Sell |
5,584,408
-371,166
| -6% | -$30.8M | 0.07% | 275 |
|
|
2020
Q3 | $475M | Buy |
5,955,574
+619,867
| +12% | +$48.4M | 0.06% | 263 |
|
|
2020
Q2 | $369M | Sell |
5,335,707
-81,747
| -2% | -$5.81M | 0.06% | 301 |
|
|
2020
Q1 | $341M | Buy |
5,417,454
+77,985
| +1% | +$5.62M | 0.06% | 277 |
|
|
2019
Q4 | $415M | Buy |
5,339,469
+82,998
| +2% | +$6.48M | 0.06% | 305 |
|
|
2019
Q3 | $385M | Sell |
5,256,471
-587,355
| -10% | -$41.3M | 0.06% | 315 |
|
|
2019
Q2 | $360M | Sell |
5,843,826
-771,600
| -12% | -$46.7M | 0.05% | 330 |
|
|
2019
Q1 | $422M | Buy |
6,615,426
+24,483
| +0.4% | +$1.4M | 0.07% | 286 |
|
|
2018
Q4 | $337M | Sell |
6,590,943
-550,311
| -8% | -$27.8M | 0.06% | 312 |
|
|
2018
Q3 | $414M | Sell |
7,141,254
-73,329
| -1% | -$3.59M | 0.06% | 287 |
|
|
2018
Q2 | $350M | Sell |
7,214,583
-402,189
| -5% | -$18.8M | 0.06% | 306 |
|
|
2018
Q1 | $354M | Buy |
7,616,772
+1,763,211
| +30% | +$76.6M | 0.06% | 301 |
|
|
2017
Q4 | $220M | Sell |
5,853,561
-830,658
| -12% | -$30.5M | 0.04% | 424 |
|
|
2017
Q3 | $244M | Buy |
6,684,219
+896,931
| +15% | +$34.2M | 0.04% | 410 |
|
|
2017
Q2 | $228M | Sell |
5,787,288
-451,053
| -7% | -$16.5M | 0.05% | 394 |
|
|
2017
Q1 | $196M | Buy |
6,238,341
+246,924
| +4% | +$7.73M | 0.04% | 414 |
|
|
2016
Q4 | $187M | Buy |
5,991,417
+1,678,857
| +39% | +$54.4M | 0.04% | 423 |
|
|
2016
Q3 | $173M | Buy |
4,312,560
+544,482
| +14% | +$20.5M | 0.04% | 437 |
|
|
2016
Q2 | $125M | Sell |
3,768,078
-416,274
| -10% | -$14.2M | 0.03% | 539 |
|
|
2016
Q1 | $123M | Buy |
4,184,352
+735,972
| +21% | +$20.3M | 0.03% | 523 |
|
|
2015
Q4 | $90.8M | Sell |
3,448,380
-239,106
| -6% | -$6.21M | 0.02% | 701 |
|
|
2015
Q3 | $87.4M | Buy |
3,687,486
+1,939,710
| +111% | +$46.8M | 0.02% | 698 |
|
|
2015
Q2 | $41.5M | Buy |
1,747,776
+36,456
| +2% | +$823K | 0.01% | 949 |
|
|
2015
Q1 | $40.6M | Sell |
1,711,320
-82,980
| -5% | -$1.86M | 0.01% | 930 |
|
|
2014
Q4 | $38.1M | Buy |
1,794,300
+685,074
| +62% | +$13.8M | 0.01% | 990 |
|
|
2014
Q3 | $18.9M | Sell |
1,109,226
-112,326
| -9% | -$1.77M | 0.01% | 1448 |
|
|
2014
Q2 | $17.5M | Buy |
1,221,552
+349,176
| +40% | +$4.73M | 0.01% | 1495 |
|
|
2014
Q1 | $10.8M | Sell |
872,376
-219,738
| -20% | -$2.54M | ﹤0.01% | 1724 |
|
|
2013
Q4 | $12M | Sell |
1,092,114
-675,540
| -38% | -$7.62M | ﹤0.01% | 1675 |
|
|
2013
Q3 | $20.5M | Buy |
1,767,654
+268,380
| +18% | +$3.14M | 0.01% | 1259 |
|
|
2013
Q2 | $16.8M | Buy |
+1,499,274
| New | +$17.7M | 0.01% | 1336 |
|
Other funds holding EW
VCM
VPM
Bank of America's EW Position: Q1 2026 in Review
Bank of America increased its Edwards Lifesciences (EW) stake by 132% in Q1 2026, buying an estimated $182M and bringing the position to 3,883,419 shares worth $311M. The position accounts for 0.02% of the portfolio, ranked #553.
Bank of America first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $690M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Bank of America held 3,883,419 shares of Edwards Lifesciences worth $311M as of Q1 2026.
- Bank of America bought 2,212,208 Edwards Lifesciences shares in Q1 2026, an estimated $182M.
- Edwards Lifesciences made up 0.02% of Bank of America's portfolio in Q1 2026, its #553 holding.
- Bank of America first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Edwards Lifesciences position peaked at $690M in Q4 2021.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.